Cardiotoxicity due to chemotherapy for breast cancer: The dark side of the moon

References (11)

1. Mann DL, Krone RJ. Cardiac disease in cancer patients: an overview. Prog Cardiovasc Dis 2010
2. [CrossRef] 2. Lotrionte M, Biondi-Zoccai G, Abbate A, Lanzetta G, D'Ascenzo F, Malavasi V, et al. Review and meta-analysis of incidence and clinical predictors of anthracycline cardiotoxicity. Am J Cardiol 2013
3. [CrossRef] 3. Hong RA, Iimura T, Sumida KN, Eager RM. Cardio-oncology/oncocardiology. Clin Cardiol 2010
4. [CrossRef] 4. Villarraga HR, Herrmann J, Nkomo VT. Cardio-oncology: role of echocardiography. Prog Cardiovasc Dis 2014
5. [CrossRef] 5. Alıcı H, Balakan O, Ercan S, Çakıcı M, Yavuz F, Davutoğlu V. Evaluation of early subclinical cardiotoxicity of chemotherapy in breast cancer. Anadolu Kardiyol Derg 2014 Apr 2. Epub ahead of print. [CrossRef] 6. Lotrionte M, Palazzoni G, Natali R, Comerci G, Abbate A, Loperfido F, et al. Assessment of left ventricular systolic dysfunction by tissue Doppler imaging to detect subclinical cardiomyopathy early after anthracycline therapy. Minerva Cardioangiol 2007
6. Lotrionte M, Palazzoni G, Abbate A, De Marco E, Mezzaroma E, Di Persio S, et al. Cardiotoxicity of a non-pegylated liposomal doxorubicin-based regimen versus an epirubicin-based regimen for breast cancer: the LITE (Liposomal doxorubicin-Investigational chemotherapy-Tissue Doppler imaging Evaluation) randomized pilot study. Int J Cardiol 2013
7. [CrossRef] 8. Lotrionte M, Cavarretta E, Abbate A, Mezzaroma E, De Marco E, Di Persio S, et al. Temporal changes in standard and tissue Doppler imaging echocardiographic parameters after anthracycline chemotherapy in women with breast cancer. Am J Cardiol 2013
8. [CrossRef] 9. Airoldi M, Amadori D, Barni S, Cinieri S, De Placido S, Di Leo A, et al. Clinical activity and cardiac tolerability of non-pegylated liposomal doxorubicin in breast cancer: a synthetic review. Tumori 2011
9. Ylänen K, Eerola A, Vettenranta K, Poutanen T. Three-dimensional echocardiography and cardiac magnetic resonance imaging in the screening of long-term survivors of childhood cancer after cardiotoxic therapy. Am J Cardiol 2014
10. [CrossRef] 11. Seicean S, Seicean A, Alan N, Plana JC, Budd GT, Marwick TH. Cardioprotective effect of β-adrenoceptor blockade in patients with breast cancer undergoing chemotherapy: follow-up study of heart failure. Circ Heart Fail 2013
11. [CrossRef] 12. Peruzzi M, De Luca L, Thomsen HS, Romagnoli E, D'Ascen